New Mucon Series K2P Powered Iris Valve Technology

Article

Mucon a division of Process Components Ltd has launched its new Series K2P electrically / pneumatically actuated range of Iris valves. The Mucon brand of Iris diaphragm valves has for over sixty years been associated with the control of powders, granules, capsules and pellets to the Pharmaceutical, Chemical and Food processing sectors.

New Mucon Series K2P Powered Iris Valve Technology

Mucon a division of Process Components Ltd has launched its new Series K2P electrically / pneumatically actuated range of Iris valves. The Mucon brand of Iris diaphragm valves has for over sixty years been associated with the control of powders, granules, capsules and pellets to the Pharmaceutical, Chemical and Food processing sectors.
Now in its second generation, the Series K2 Powered Iris Valves have been specifically designed for automatic and remote applications, complimenting the popular hand operated versions.

Developed for applications requiring a high level of hygiene, this valve utilises our patented, moulded diaphragm technology already employed throughout the K-Valve range.

Mucon Engineers have taken great care to balance customer requirements for quick disconnect, ease of cleaning and hygienic design with the requirements for reliability and control system integration.

All body parts are manufactured from 316 stainless steel, as standard. White moulded diaphragms of Natural Rubber, EPDM and Silicone are all manufactured from FDA approved materials.

The salient features and benefits of the new MUCON K2P valve are as follows;

  • Extensively used in the Pharmaceutical, Chemical and Food sectors

  • FDA approved diaphragm materials

  • Full product flow control

  • Non-Jamming

  • No mechanical parts in contact with the product

  • Slim Design

  • Electric and Pneumatic actuation

  • ATEX approved Cat. 1D / 2D
Recent Videos
Miguel Forte from ISCT and Kiji Therapeutics talks about the potential impact of a changing European political landscape.
Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the changing political landscape in the US as well as legislative and regulatory adjustments
Miguel Forte from ISCT and Kiji Therapeutics chats about expectations for 2025 and the future technology agenda for industry.
Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.
Mike Baird from Schlafender Hase gives his predictions for how AI and ML may find use in the industry moving forwards and provides some predictions about M&A and the changing US government administration.
Mike Baird from Schlafender Haser discusses industry trends from 2024 and those expected to have an impact in 2025 from the perspective of a software developer.
Preeya Beczek from Beczek.COM gives her thoughts on the areas to watch with the new US administration and how Europe might be finalizing preparations for previous legislative changes
Related Content